Maria E. Tiboni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria E. Tiboni has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Alben Sigamani
Carmel Research Consultancy Pvt Ltd, Bengaluru, India
3 shared publications - Ameen Patel
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
3 shared publications - Flavia Kessler Borges
Department of Medicine, McMaster University, Hamilton, ON, Canada
3 shared publications - Philip James Devereaux
Population Health Research Institute, McMaster University, Hamilton, ON, Canada
3 shared publications - Vikas Tandon
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
3 shared publications - Bruce McClure Biccard
Department of Anaesthesia and Perioperative Medicine, University of Cape Town Faculty of Health Sciences, Observatory, Western Cape, South Africa
2 shared publications
Latest Publications
- 27 October 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 144 (2) , 289-300
Pain as a Driver of Myocardial Injury in Hip Fracture Patients: A Hip Fracture Accelerated Surgical Treatment and Care Track (HIP ATTACK) Trial Secondary Analysis
Background: Pain is a common yet underaddressed issue in surgical inpatients. Inadequate pain control in patients with hip fractures can lead to adverse hemodynamic changes, potentially increasing the risk of myocardial ischemia. The authors aim to investigate whether perioperative pain is associated with the development of myocardial ischemic events in patients undergoing hip fracture surgery. Methods: HIP fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) was a multicenter international randomized controlled trial comparing the effects of accelerated surgical repair of hip fracture versus standard of care. The authors included patients enrolled in the HIP ATTACK trial who had at least one troponin measurement and a pain score measurement. Pain was assessed daily on hospital admission using the 0 to 10 numeric rating scale. The primary analysis included all available pain scores averaged (then categorized as mild [numeric rating scale 0 to 3], moderate [4 to 7], and severe [8 to 10] pain) before and on the day of the first troponin elevation. The primary outcome was troponin elevation from any cause, with secondary outcomes of myocardial injury (due to an ischemic etiology), myocardial infarction, and then a composite of myocardial injury and myocardial infarction. Multivariable regression models adjusting for potential confounders were used to identify an association between pain categories and outcomes. Results: The authors included 2,430 (82%) from the initial HIP ATTACK cohort (n = 2,970). Forty-five percent of patients (1,098) suffered a troponin elevation from any cause. In the adjusted models, moderate (odds ratio, 3.90; 95% CI, 3.02 to 5.05) and severe pain (odds ratio, 29.24; 95% CI, 17.7 to 48.29) were associated with a troponin elevation of any cause. Similarly, moderate (odds ratio, 2.09; 95% CI, 1.71 to 2.57) and severe pain (odds ratio, 6.04, 95% CI, 4.49 to 8.12) were associated with myocardial injury, whereas only severe pain was associated with myocardial infarction (odds ratio, 2.33; 95% CI, 1.35 to 3.99). Both moderate and severe pain were associated with the composite outcome. Conclusions: Increased pain may be associated with myocardial ischemic events in the perioperative period in hip fracture patients. Future research is needed to confirm and further clarify this relationship and to determine whether analgesic interventions can reduce the risk of perioperative myocardial ischemia.
- 27 October 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 144 (2) , 289-300
Pain as a Driver of Myocardial Injury in Hip Fracture Patients: A Hip Fracture Accelerated Surgical Treatment and Care Track (HIP ATTACK) Trial Secondary Analysis
Background: Pain is a common yet underaddressed issue in surgical inpatients. Inadequate pain control in patients with hip fractures can lead to adverse hemodynamic changes, potentially increasing the risk of myocardial ischemia. The authors aim to investigate whether perioperative pain is associated with the development of myocardial ischemic events in patients undergoing hip fracture surgery. Methods: HIP fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) was a multicenter international randomized controlled trial comparing the effects of accelerated surgical repair of hip fracture versus standard of care. The authors included patients enrolled in the HIP ATTACK trial who had at least one troponin measurement and a pain score measurement. Pain was assessed daily on hospital admission using the 0 to 10 numeric rating scale. The primary analysis included all available pain scores averaged (then categorized as mild [numeric rating scale 0 to 3], moderate [4 to 7], and severe [8 to 10] pain) before and on the day of the first troponin elevation. The primary outcome was troponin elevation from any cause, with secondary outcomes of myocardial injury (due to an ischemic etiology), myocardial infarction, and then a composite of myocardial injury and myocardial infarction. Multivariable regression models adjusting for potential confounders were used to identify an association between pain categories and outcomes. Results: The authors included 2,430 (82%) from the initial HIP ATTACK cohort (n = 2,970). Forty-five percent of patients (1,098) suffered a troponin elevation from any cause. In the adjusted models, moderate (odds ratio, 3.90; 95% CI, 3.02 to 5.05) and severe pain (odds ratio, 29.24; 95% CI, 17.7 to 48.29) were associated with a troponin elevation of any cause. Similarly, moderate (odds ratio, 2.09; 95% CI, 1.71 to 2.57) and severe pain (odds ratio, 6.04, 95% CI, 4.49 to 8.12) were associated with myocardial injury, whereas only severe pain was associated with myocardial infarction (odds ratio, 2.33; 95% CI, 1.35 to 3.99). Both moderate and severe pain were associated with the composite outcome. Conclusions: Increased pain may be associated with myocardial ischemic events in the perioperative period in hip fracture patients. Future research is needed to confirm and further clarify this relationship and to determine whether analgesic interventions can reduce the risk of perioperative myocardial ischemia.
- 25 July 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (24) , 2303-2312
Myocardial Injury in Patients with Hip Fracture
Background: Myocardial injury after a hip fracture is common and has a poor prognosis. Patients with a hip fracture and myocardial injury may benefit from accelerated surgery to remove the physiological stress associated with the hip fracture. This study aimed to determine if accelerated surgery is superior to standard care in terms of the 90-day risk of death in patients with a hip fracture who presented with an elevated cardiac biomarker/enzyme measurement at hospital arrival. Methods: The HIP fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) trial was a randomized controlled trial designed to determine whether accelerated surgery for hip fracture was superior to standard care in reducing death or major complications. This substudy is a post-hoc analysis of 1392 patients (from the original study of 2970 patients) who had a cardiac biomarker/enzyme measurement (>99.9% had a troponin measurement and thus “troponin” is the term used throughout the paper) at hospital arrival. The primary outcome was all-cause mortality. The secondary composite outcome included all-cause mortality and non-fatal myocardial infarction, stroke, and congestive heart failure 90 days after randomization. Results: Three hundred and twenty-two (23%) of the 1392 patients had troponin elevation at hospital arrival. Among the patients with troponin elevation, the median time from hip fracture diagnosis to surgery was 6 hours (interquartile range [IQR] = 5 to 13) in the accelerated surgery group and 29 hours (IQR = 19 to 52) in the standard care group. Patients with troponin elevation had a lower risk of mortality with accelerated surgery compared with standard care (17 [10%] of 163 versus 36 [23%] of 159; hazard ratio [HR] = 0.43 [95% confidence interval (CI) = 0.24 to 0.77]) and a lower risk of the secondary composite outcome (23 [14%] of 163 versus 47 [30%] of 159; HR = 0.43 [95% CI = 0.26 to 0.72]). Conclusions: One in 5 patients with a hip fracture presented with myocardial injury. Accelerated surgery resulted in a lower mortality risk than standard care for these patients; however, these findings need to be confirmed. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
- 25 July 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (24) , 2303-2312
Myocardial Injury in Patients with Hip Fracture
Background: Myocardial injury after a hip fracture is common and has a poor prognosis. Patients with a hip fracture and myocardial injury may benefit from accelerated surgery to remove the physiological stress associated with the hip fracture. This study aimed to determine if accelerated surgery is superior to standard care in terms of the 90-day risk of death in patients with a hip fracture who presented with an elevated cardiac biomarker/enzyme measurement at hospital arrival. Methods: The HIP fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) trial was a randomized controlled trial designed to determine whether accelerated surgery for hip fracture was superior to standard care in reducing death or major complications. This substudy is a post-hoc analysis of 1392 patients (from the original study of 2970 patients) who had a cardiac biomarker/enzyme measurement (>99.9% had a troponin measurement and thus “troponin” is the term used throughout the paper) at hospital arrival. The primary outcome was all-cause mortality. The secondary composite outcome included all-cause mortality and non-fatal myocardial infarction, stroke, and congestive heart failure 90 days after randomization. Results: Three hundred and twenty-two (23%) of the 1392 patients had troponin elevation at hospital arrival. Among the patients with troponin elevation, the median time from hip fracture diagnosis to surgery was 6 hours (interquartile range [IQR] = 5 to 13) in the accelerated surgery group and 29 hours (IQR = 19 to 52) in the standard care group. Patients with troponin elevation had a lower risk of mortality with accelerated surgery compared with standard care (17 [10%] of 163 versus 36 [23%] of 159; hazard ratio [HR] = 0.43 [95% confidence interval (CI) = 0.24 to 0.77]) and a lower risk of the secondary composite outcome (23 [14%] of 163 versus 47 [30%] of 159; HR = 0.43 [95% CI = 0.26 to 0.72]). Conclusions: One in 5 patients with a hip fracture presented with myocardial injury. Accelerated surgery resulted in a lower mortality risk than standard care for these patients; however, these findings need to be confirmed. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
- 15 September 2023
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 140 (1) , 8-24
One-year Outcomes after Discharge from Noncardiac Surgery and Association between Predischarge Complications and Death after Discharge: Analysis of the VISION Prospective Cohort Study
Background: In previous analyses, myocardial injury after noncardiac surgery, major bleeding, and sepsis were independently associated with most deaths in the 30 days after noncardiac surgery, but most of these deaths occurred during the index hospitalization for surgery. The authors set out to describe outcomes after discharge from hospital up to 1 yr after inpatient noncardiac surgery and associations between predischarge complications and postdischarge death up to 1 yr after surgery. Methods: This study was an analysis of patients discharged after inpatient noncardiac surgery in a large international prospective cohort study across 28 centers from 2007 to 2013 of patients aged 45 yr or older followed to 1 yr after surgery. The study estimated (1) the cumulative postdischarge incidence of death and other outcomes up to a year after surgery and (2) the adjusted time-varying associations between postdischarge death and predischarge complications including myocardial injury after noncardiac surgery, major bleeding, sepsis, infection without sepsis, stroke, congestive heart failure, clinically important atrial fibrillation or flutter, amputation, venous thromboembolism, and acute kidney injury managed with dialysis. Results: Among 38,898 patients discharged after surgery, the cumulative 1-yr incidence was 5.8% (95% CI, 5.5 to 6.0%) for all-cause death and 24.7% (95% CI, 24.2 to 25.1%) for all-cause hospital readmission. Predischarge complications were associated with 33.7% (95% CI, 27.2 to 40.2%) of deaths up to 30 days after discharge and 15.0% (95% CI, 12.0 to 17.9%) up to 1 yr. Most of the association with death was due to myocardial injury after noncardiac surgery (15.6% [95% CI, 9.3 to 21.9%] of deaths within 30 days, 6.4% [95% CI, 4.1 to 8.7%] within 1 yr), major bleeding (15.0% [95% CI, 8.3 to 21.7%] within 30 days, 4.7% [95% CI, 2.2 to 7.2%] within 1 yr), and sepsis (5.4% [95% CI, 2.2 to 8.6%] within 30 days, 2.1% [95% CI, 1.0 to 3.1%] within 1 yr). Conclusions: One in 18 patients 45 yr old or older discharged after inpatient noncardiac surgery died within 1 yr, and one quarter were readmitted to the hospital. The risk of death associated with predischarge perioperative complications persists for weeks to months after discharge. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New:
- 15 September 2023
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 140 (1) , 8-24
One-year Outcomes after Discharge from Noncardiac Surgery and Association between Predischarge Complications and Death after Discharge: Analysis of the VISION Prospective Cohort Study
Background: In previous analyses, myocardial injury after noncardiac surgery, major bleeding, and sepsis were independently associated with most deaths in the 30 days after noncardiac surgery, but most of these deaths occurred during the index hospitalization for surgery. The authors set out to describe outcomes after discharge from hospital up to 1 yr after inpatient noncardiac surgery and associations between predischarge complications and postdischarge death up to 1 yr after surgery. Methods: This study was an analysis of patients discharged after inpatient noncardiac surgery in a large international prospective cohort study across 28 centers from 2007 to 2013 of patients aged 45 yr or older followed to 1 yr after surgery. The study estimated (1) the cumulative postdischarge incidence of death and other outcomes up to a year after surgery and (2) the adjusted time-varying associations between postdischarge death and predischarge complications including myocardial injury after noncardiac surgery, major bleeding, sepsis, infection without sepsis, stroke, congestive heart failure, clinically important atrial fibrillation or flutter, amputation, venous thromboembolism, and acute kidney injury managed with dialysis. Results: Among 38,898 patients discharged after surgery, the cumulative 1-yr incidence was 5.8% (95% CI, 5.5 to 6.0%) for all-cause death and 24.7% (95% CI, 24.2 to 25.1%) for all-cause hospital readmission. Predischarge complications were associated with 33.7% (95% CI, 27.2 to 40.2%) of deaths up to 30 days after discharge and 15.0% (95% CI, 12.0 to 17.9%) up to 1 yr. Most of the association with death was due to myocardial injury after noncardiac surgery (15.6% [95% CI, 9.3 to 21.9%] of deaths within 30 days, 6.4% [95% CI, 4.1 to 8.7%] within 1 yr), major bleeding (15.0% [95% CI, 8.3 to 21.7%] within 30 days, 4.7% [95% CI, 2.2 to 7.2%] within 1 yr), and sepsis (5.4% [95% CI, 2.2 to 8.6%] within 30 days, 2.1% [95% CI, 1.0 to 3.1%] within 1 yr). Conclusions: One in 18 patients 45 yr old or older discharged after inpatient noncardiac surgery died within 1 yr, and one quarter were readmitted to the hospital. The risk of death associated with predischarge perioperative complications persists for weeks to months after discharge. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New: